Industry: Sleep tech
Funding for sleep startups
Sleep tech now runs from smart beds and sleep earbuds to home sleep tests and apnea implants. We help founders show investors who pays, how often and what regulators have cleared.
- Sourced data on smart beds, sleep audio, apps and sleep apnea care
- Decks and models built on clearances, payers and repeat revenue
- Waveup prepares investor materials for sleep tech companies: $3B+ raised for 600+ startups since 2014
In short
What is sleep tech startup funding?
Sleep tech startup funding is the money raised by companies that help people sleep or treat sleep disorders. That covers smart beds, sleep earbuds, apps, home sleep tests and apnea devices. Angels, health and consumer VCs and device makers such as ResMed back them. A 2019 Lancet study put adults aged 30 to 69 with sleep apnea at 936 million worldwide.
- Who it's for
- Sleep device, app, testing and therapy companies, pre-seed to Series D+
- What we build
- Investor deck, financial model, valuation, investor list, data room
- Prices
- Deck from $6,000, model from $3,000. Flat fees
- Track record
- $3B+ raised for 600+ startups since 2014
Market data checked on 6 November 2026. Sources are under each section.
Why do investors care about sleep in 2026?
Because poor sleep is common and most sleep apnea goes untreated. But 2026 also showed that a sleep company needs repeat revenue or a payer to last.
The opportunity
Most people with sleep apnea have never been diagnosed, and more care now starts at home.
- Home tests let doctors check for sleep apnea without a sleep lab
- Earbuds, smart mattress covers and apps sell straight to sleepers
- Device makers buy sleep startups: ResMed bought Noctrix Health in 2026
The problem
Smart bed maker Sleep Number filed for bankruptcy protection in June 2026. On the clinical side, sales of Inspire's sleep apnea implant fell 7.9% in Q3 2026.
Market size
How big is the sleep tech market?
Nobody keeps an official count of the whole sleep tech market. Listed companies give a floor. ResMed, which makes CPAP machines, masks and care software, had $5.7B of revenue in fiscal 2026. Four areas show where the money goes:
- Diagnosis: more than 80% of sleep apnea cases go undiagnosed and untreated, ResMed says
- Implants: Inspire's sleep apnea implant brought in $912M of revenue in 2025
- Restless legs: about 8% of adults report symptoms, and ResMed now owns a non-drug treatment
- Sleep audio: Ozlo's sleep earbuds passed 260,000 customers in under two years
Venture capital
How much do sleep startups raise, and who buys them?
No public tracker counts sleep tech rounds on their own, so single deals show the trend. Crunchbase found the largest recent rounds went to sleep monitoring, sleep apnea treatment and diagnostic tools.
ResMed's total purchase price for Noctrix Health, a restless legs startup it already part-owned, in June 2026
in cash paid by Sleep Country Canada for Sleep Number's assets in July 2026
of equity investments on ResMed's books at 30 June 2026
Who invests in sleep tech startups?
Early-stage and deep tech VCs, a device maker that takes stakes and buys, and a mattress retailer that buys. For more health investors, see our list of healthcare venture capital firms.
Investor database
Healthtech investors in our database
The funds with the most healthtech investments. Pick a stage, or open a fund for its cheque sizes.
Top 5 by healthtech investments
Investments by industry
- Healthtech & Wellness48%
- Biotech24%
- Pharma21%
- Rounds
- Series ASeries BSeries C+
- Average cheque
- $500K–$1M$1M–$3M$3M–$10M$10M–$50M
- Based in
- New York, United States
- Invests in
- East Asia, USA
704 investments in total, 49 tagged Healthtech & Wellness.Open the full fund profile
Investments by industry
- Healthtech & Wellness42%
- Biotech26%
- Pharma18%
- Rounds
- SeedSeries ASeries BSeries C+
- Average cheque
- $100K–$500K$500K–$1M
- Based in
- Cambridge, United States
- Invests in
- Southeast Asia, USA
613 investments in total, 40 tagged Healthtech & Wellness.Open the full fund profile
Investments by industry
- Healthtech & Wellness56%
- Software & Apps12%
- AI & Deep Tech7%
- Rounds
- SeedSeries ASeries BSeries C+
- Average cheque
- $3M–$10M$10M–$50M
- Based in
- San Francisco, USA
- Invests in
- USA
83 investments in total, 38 tagged Healthtech & Wellness.Open the full fund profile
Investments by industry
- Healthtech & Wellness45%
- Biotech30%
- Pharma19%
- Rounds
- Series ASeries BSeries C+
- Average cheque
- $0–$100K$100K–$500K$500K–$1M$1M–$3M$3M–$10M
- Based in
- Menlo Park, United States
- Invests in
- Europe, USA, Canada
382 investments in total, 30 tagged Healthtech & Wellness.Open the full fund profile
Investments by industry
- Software & Apps36%
- AI & Deep Tech17%
- Healthtech & Wellness16%
- Rounds
- SeedSeries ASeries BSeries C+
- Average cheque
- $3M–$10MOver $50M$10M–$50M
- Based in
- Boston, United States
315 investments in total, 27 tagged Healthtech & Wellness.Open the full fund profile
From our investor database.
What do sleep investors worry about in 2026?
In our Fundraising 2025 study, 56 VCs named their top reasons to pass. First came revenue growth, unit economics, burn and missed milestones, then defensibility and crowded categories. In sleep tech, they show up in four places.
Drugs that treat sleep apnea
In December 2024, the FDA approved Zepbound for moderate to severe sleep apnea in adults with obesity. Investors also put $80M into Mosanna, which is developing a nasal spray for sleep apnea.
What investors ask
- How many of your patients could treat sleep apnea with a drug instead?
What your deck shows
- Who still needs your product if drug use grows
- How you serve patients who also take these drugs
Billing codes set the pace
Inspire's revenue fell 7.9% in Q3 2026, which it blamed on coding and reimbursement challenges. New billing codes for its newest implant take effect only in January 2028.
What investors ask
- Which billing code pays for your product, and what if it changes?
What your deck shows
- The codes, payers and payment rates you rely on
- Sales split by insurers, Medicare and cash buyers
Big-ticket beds when money is tight
Sleep Number's sales fell 35% from 2021 to 2025. It filed for bankruptcy protection in June 2026 and expects no sale proceeds to reach shareholders.
What investors ask
- Will people still pay thousands for a bed in a bad year?
What your deck shows
- Sales and margin by price point and channel
- Revenue after the first sale, such as covers, parts or subscriptions
Paying users who drift away
Sleep Cycle, which makes a sleep-tracking app, lost about a quarter of its paying subscribers in the year to Q3 2026. It said new sales in the App Store remain challenging.
What investors ask
- How many sleepers still pay you a year after they sign up?
What your deck shows
- Retention by monthly cohort, net of refunds
- Sales channels beyond app stores, such as employers or health plans
How we help you raise
Flat fees agreed before we start. No success fee on advisory work.
The sleeper's problem, who pays and your proof, in one story.
Device margins, resupply, subscriptions and the cash to reach them.
A range set against recent sleep deals and listed device makers.
Health VCs, consumer funds and device makers that fit your stage.
Clearances, test data, supplier contracts and IP, ready to check.
For a sale to a device maker, a mattress group or a retailer.
Who we are
Waveup is a London-based fundraising and growth advisory, working in 60+ countries and 90+ industries. Since 2014 we have built the decks, models, CIMs and valuations behind $3B+ raised for 600+ startups.
About usSleep startup funding FAQ
What is sleep tech?
How do sleep tech startups raise money?
Do investors still fund sleep startups in 2026?
Who buys sleep tech companies?
What do investors look for in a sleep tech startup?
How much does help with a sleep tech raise cost?
Raising for a sleep tech company?
Tell us what you sell, who pays for it and how much you need. We'll show you where investors will push first.





